- PWSID
- PA3060088
- State
- Pennsylvania
- System type
- community water system (CWS)
- Population served
- 24,951
- City
- Mechanicsburg
- Counties
- Berks County
- Primary source water
- surface water (purchased)
- UCMR 5 sampling
- 2024-03-05 to 2024-12-12 · 12 entry point(s) · water types: GW;SW
- Service-area boundary
- authoritative
PFOS ≥ 3 × its limit highest single result
PFOS 1–3 × its limit worst entry-point average
Open on the Pennsylvania map · All Pennsylvania systems · All results
These are monitoring results collected under EPA's Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) at entry points, where treated water enters the distribution system; they are not tap-water samples. They are not compliance determinations: compliance with EPA's 2024 PFAS limits is judged on running annual averages of compliance monitoring, required from 2029, so a single UCMR 5 result at or above a limit is not a violation. “< MRL” means the compound was not quantified at EPA's minimum reporting level; it does not mean zero.
Water purchased from
- Mt Penn Boro Muni Auth (PA3060082)
Seller's highest results: PFOA <MRL · PFOS 5.7 ppt · HI 0.77 · detected: PFNA;PFOS - Reading Area Water Authority (PA3060059)
Seller's highest results: PFOA 6.6 ppt · PFOS <MRL · HI 0.003 · detected: PFBS;PFHpA;PFHxA;PFOA;PFPeA
Seller results are the seller's own entry-point samples, not measurements of this system's water. This system's own samples (below) may reflect purchased water, its own sources, or both.
Compared with EPA's 2024 values
| Highest single result | Worst entry-point average* | Limit | |
|---|---|---|---|
| PFOA (ppt) | 5.8 | 5.15 | 4 |
| PFOS (ppt) | 12.7 | 11.6 | 4 |
| Hazard Index | 0.544 | 0.494 | 1.0† |
“<MRL” = every result for the compound was below its reporting limit. * Mean of all samples at each entry point with non-detects = 0 (EPA compliance convention; the Hazard Index also uses non-detects = 0); a screening comparison, not a formal running annual average. † Rescission proposed May 2026. PFOA/PFOS MCL 4 ppt (2024 NPDWR, in effect). PFHxS, PFNA, HFPO-DA (10 ppt each) and the Hazard Index (1.0) are 2024 NPDWR values; EPA proposed rescinding them on 18 May 2026 (comment period closed 20 Jul 2026).
Compared with Pennsylvania standards
| Highest single result | Worst entry-point average* | Pennsylvania | |
|---|---|---|---|
| PFOA (ppt) | 5.8 | 5.15 | 14 |
| PFOS (ppt) | 12.7 | 11.6 | 18 |
Sum standards add the listed compounds within each sample (non-detects = 0). State compliance is normally judged on averages over time; these are screening comparisons.
Sampling history
Sampled 2024-03-05 to 2024-12-12 · 12 entry point(s) · water types: GW;SW · 28 sampling visits. PFAS in ppt (ng/L).
| Date | Entry point | Event | PFOA | PFOS | HI | Other detections |
|---|---|---|---|---|---|---|
| 2024-03-05 | Butter Lane Plant (GW) | SE1 | <4 | <4 | 0 | none |
| 2024-03-05 | Gl #2A Wellhouse Treatment (GW) | SE1 | 4.8 | 6.4 | 0.003 | PFHxA 3.5, PFPeA 3.9, lithium 18.2 µg/L |
| 2024-03-05 | Mt. Penn Bingaman Connection (GW) | SE1 | <4 | <4 | 0 | lithium 13.4 µg/L |
| 2024-03-05 | Mt. Penn Seidel Connection (GW) | SE1 | <4 | <4 | 0 | lithium 13.5 µg/L |
| 2024-03-05 | RAWA Woodvale Connection (SW) | SE1 | 5 | <4 | 0.002 | PFHxA 3.1, PFPeA 3.4 |
| 2024-03-05 | Wellhouse #8 Treatment (GW) | SE1 | 4.6 | 12.7 | 0.544 | PFHxA 3.8, PFPeA 4.5 |
| 2024-03-05 | Wellhouse #9A Treatment (GW) | SE1 | 4.6 | 7.9 | 0.002 | PFHxA 3.6, PFPeA 3.7 |
| 2024-03-07 | Douglassville #11 Treatment (GW) | SE1 | n/a | n/a | n/a | none |
| 2024-03-07 | Douglassville #12A Treatment (GW) | SE1 | <4 | <4 | 0.002 | lithium 9.6 µg/L |
| 2024-03-07 | Douglassville #13 Treatment (GW) | SE1 | n/a | n/a | n/a | lithium 24.2 µg/L |
| 2024-03-07 | Monk Dr. #6 Treatment (GW) | SE1 | 5.2 | 6.7 | 0.382 | lithium 42.5 µg/L |
| 2024-03-07 | Nicholson #3 & #4 Treatment (GW) | SE1 | <4 | <4 | 0 | lithium 42.5 µg/L |
| 2024-03-28 | Douglassville #11 Treatment (GW) | SE1 | <4 | <4 | 0.002 | none |
| 2024-04-04 | Douglassville #13 Treatment (GW) | SE1 | <4 | <4 | 0.007 | PFHxA 4.5, PFPeA 3.5 |
| 2024-06-03 | RAWA Woodvale Connection (SW) | SE2 | 5.8 | <4 | 0.002 | PFHxA 3.6, PFPeA 4.2 |
| 2024-09-05 | Butter Lane Plant (GW) | SE2 | <4 | <4 | 0 | none |
| 2024-09-05 | Mt. Penn Seidel Connection (GW) | SE2 | <4 | <4 | 0 | lithium 12.4 µg/L |
| 2024-09-05 | Wellhouse #9A Treatment (GW) | SE2 | 4.3 | 8.1 | 0.003 | PFHxA 3.8, PFPeA 4.1 |
| 2024-09-09 | Mt. Penn Bingaman Connection (GW) | SE2 | <4 | <4 | 0 | lithium 12.8 µg/L |
| 2024-09-09 | RAWA Woodvale Connection (SW) | SE3 | 5.2 | <4 | 0.002 | PFBA 5.1, PFHxA 3.7, PFPeA 4.6 |
| 2024-09-09 | Wellhouse #8 Treatment (GW) | SE2 | 4.2 | 10.5 | 0.444 | PFHxA 3.8, PFPeA 4.6 |
| 2024-09-12 | Douglassville #11 Treatment (GW) | SE2 | <4 | <4 | 0.002 | none |
| 2024-09-12 | Douglassville #12A Treatment (GW) | SE2 | <4 | 5.3 | 0.38 | lithium 16.9 µg/L |
| 2024-09-12 | Douglassville #13 Treatment (GW) | SE2 | <4 | <4 | 0.015 | PFHxA 6, PFPeA 4.3, lithium 26.4 µg/L |
| 2024-09-12 | Gl #2A Wellhouse Treatment (GW) | SE2 | 4.6 | 5.7 | 0.003 | PFHxA 3.8, PFPeA 4.2, lithium 16.9 µg/L |
| 2024-09-12 | Monk Dr. #6 Treatment (GW) | SE2 | 5.1 | 6.6 | 0.4 | lithium 42 µg/L |
| 2024-09-12 | Nicholson #3 & #4 Treatment (GW) | SE2 | <4 | <4 | 0 | lithium 39.8 µg/L |
| 2024-12-12 | RAWA Woodvale Connection (SW) | SE4 | 4 | <4 | 0.002 | PFHxA 3.1, PFPeA 3.6 |
“<4” = not detected at the reporting limit shown; “n/a” = not analyzed in that sample. Highlighted = at or above the 4 ppt MCL. HI computed per sample with non-detects as 0. Other detections lists every other quantified compound (lithium in µg/L).
All results by entry point
780 results. Each column is one sampling visit (date and UCMR 5 sample event). A number is a measured concentration; “< 4” = below the minimum reporting level shown; “–” = not analyzed in that visit. PFAS in ppt (ng/L); lithium in µg/L.
Butter Lane Plant facility 00101 · sample point 101 · groundwater
| Compound | MRL | 2024-03-05 SE1 | 2024-09-05 SE2 |
|---|---|---|---|
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFBS | 3 ppt | < 3 | < 3 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxA | 3 ppt | < 3 | < 3 |
| PFHxS | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFOA | 4 ppt | < 4 | < 4 |
| PFOS | 4 ppt | < 4 | < 4 |
| PFPeA | 3 ppt | < 3 | < 3 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | < 9 | < 9 |
Douglassville #11 Treatment facility 00113 · sample point 113 · groundwater
| Compound | MRL | 2024-03-07 SE1 | 2024-03-28 SE1 | 2024-09-12 SE2 |
|---|---|---|---|---|
| PFBS | 3 ppt | – | 3.1 | 4.7 |
| 11Cl-PF3OUdS | 5 ppt | – | < 5 | < 5 |
| 4:2 FTS | 3 ppt | – | < 3 | < 3 |
| 6:2 FTS | 5 ppt | – | < 5 | < 5 |
| 8:2 FTS | 5 ppt | – | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | – | < 2 | < 2 |
| ADONA | 3 ppt | – | < 3 | < 3 |
| HFPO-DA | 5 ppt | – | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | – | < 5 |
| NFDHA | 20 ppt | – | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | – | < 6 |
| PFBA | 5 ppt | – | < 5 | < 5 |
| PFDA | 3 ppt | – | < 3 | < 3 |
| PFDoA | 3 ppt | – | < 3 | < 3 |
| PFEESA | 3 ppt | – | < 3 | < 3 |
| PFHpA | 3 ppt | – | < 3 | < 3 |
| PFHpS | 3 ppt | – | < 3 | < 3 |
| PFHxA | 3 ppt | – | < 3 | < 3 |
| PFHxS | 3 ppt | – | < 3 | < 3 |
| PFMBA | 3 ppt | – | < 3 | < 3 |
| PFMPA | 4 ppt | – | < 4 | < 4 |
| PFNA | 4 ppt | – | < 4 | < 4 |
| PFOA | 4 ppt | – | < 4 | < 4 |
| PFOS | 4 ppt | – | < 4 | < 4 |
| PFPeA | 3 ppt | – | < 3 | < 3 |
| PFPeS | 4 ppt | – | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | – | < 8 |
| PFTrDA | 7 ppt | < 7 | – | < 7 |
| PFUnA | 2 ppt | – | < 2 | < 2 |
| lithium | 9 µg/L | < 9 | – | < 9 |
Douglassville #12A Treatment facility 00112 · sample point 112 · groundwater
| Compound | MRL | 2024-03-07 SE1 | 2024-09-12 SE2 |
|---|---|---|---|
| PFBS | 3 ppt | 3.3 | < 3 |
| PFHxS | 3 ppt | < 3 | 3.8 |
| PFOS | 4 ppt | < 4 | 5.3 |
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxA | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFOA | 4 ppt | < 4 | < 4 |
| PFPeA | 3 ppt | < 3 | < 3 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | 9.6 | 16.9 |
Douglassville #13 Treatment facility 00114 · sample point 114 · groundwater
| Compound | MRL | 2024-03-07 SE1 | 2024-04-04 SE1 | 2024-09-12 SE2 |
|---|---|---|---|---|
| PFBS | 3 ppt | – | 14.7 | 29.8 |
| PFHxA | 3 ppt | – | 4.5 | 6 |
| PFPeA | 3 ppt | – | 3.5 | 4.3 |
| 11Cl-PF3OUdS | 5 ppt | – | < 5 | < 5 |
| 4:2 FTS | 3 ppt | – | < 3 | < 3 |
| 6:2 FTS | 5 ppt | – | < 5 | < 5 |
| 8:2 FTS | 5 ppt | – | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | – | < 2 | < 2 |
| ADONA | 3 ppt | – | < 3 | < 3 |
| HFPO-DA | 5 ppt | – | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | – | < 5 |
| NFDHA | 20 ppt | – | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | – | < 6 |
| PFBA | 5 ppt | – | < 5 | < 5 |
| PFDA | 3 ppt | – | < 3 | < 3 |
| PFDoA | 3 ppt | – | < 3 | < 3 |
| PFEESA | 3 ppt | – | < 3 | < 3 |
| PFHpA | 3 ppt | – | < 3 | < 3 |
| PFHpS | 3 ppt | – | < 3 | < 3 |
| PFHxS | 3 ppt | – | < 3 | < 3 |
| PFMBA | 3 ppt | – | < 3 | < 3 |
| PFMPA | 4 ppt | – | < 4 | < 4 |
| PFNA | 4 ppt | – | < 4 | < 4 |
| PFOA | 4 ppt | – | < 4 | < 4 |
| PFOS | 4 ppt | – | < 4 | < 4 |
| PFPeS | 4 ppt | – | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | – | < 8 |
| PFTrDA | 7 ppt | < 7 | – | < 7 |
| PFUnA | 2 ppt | – | < 2 | < 2 |
| lithium | 9 µg/L | 24.2 | – | 26.4 |
Gl #2A Wellhouse Treatment facility 00104 · sample point 104 · groundwater
| Compound | MRL | 2024-03-05 SE1 | 2024-09-12 SE2 |
|---|---|---|---|
| PFBS | 3 ppt | 5.1 | 5.2 |
| PFHxA | 3 ppt | 3.5 | 3.8 |
| PFOA | 4 ppt | 4.8 | 4.6 |
| PFOS | 4 ppt | 6.4 | 5.7 |
| PFPeA | 3 ppt | 3.9 | 4.2 |
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxS | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | 18.2 | 16.9 |
Monk Dr. #6 Treatment facility 00111 · sample point 111 · groundwater
| Compound | MRL | 2024-03-07 SE1 | 2024-09-12 SE2 |
|---|---|---|---|
| PFBS | 3 ppt | 3.7 | < 3 |
| PFHxS | 3 ppt | 3.8 | 4 |
| PFOA | 4 ppt | 5.2 | 5.1 |
| PFOS | 4 ppt | 6.7 | 6.6 |
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxA | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFPeA | 3 ppt | < 3 | < 3 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | 42.5 | 42 |
Mt. Penn Bingaman Connection facility 00108 · sample point 108 · groundwater
| Compound | MRL | 2024-03-05 SE1 | 2024-09-09 SE2 |
|---|---|---|---|
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFBS | 3 ppt | < 3 | < 3 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxA | 3 ppt | < 3 | < 3 |
| PFHxS | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFOA | 4 ppt | < 4 | < 4 |
| PFOS | 4 ppt | < 4 | < 4 |
| PFPeA | 3 ppt | < 3 | < 3 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | 13.4 | 12.8 |
Mt. Penn Seidel Connection facility 00115 · sample point 115 · groundwater
| Compound | MRL | 2024-03-05 SE1 | 2024-09-05 SE2 |
|---|---|---|---|
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFBS | 3 ppt | < 3 | < 3 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxA | 3 ppt | < 3 | < 3 |
| PFHxS | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFOA | 4 ppt | < 4 | < 4 |
| PFOS | 4 ppt | < 4 | < 4 |
| PFPeA | 3 ppt | < 3 | < 3 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | 13.5 | 12.4 |
Nicholson #3 & #4 Treatment facility 00110 · sample point 110 · groundwater
| Compound | MRL | 2024-03-07 SE1 | 2024-09-12 SE2 |
|---|---|---|---|
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFBS | 3 ppt | < 3 | < 3 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxA | 3 ppt | < 3 | < 3 |
| PFHxS | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFOA | 4 ppt | < 4 | < 4 |
| PFOS | 4 ppt | < 4 | < 4 |
| PFPeA | 3 ppt | < 3 | < 3 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | 42.5 | 39.8 |
RAWA Woodvale Connection facility 00107 · sample point 107 · surface water
| Compound | MRL | 2024-03-05 SE1 | 2024-06-03 SE2 | 2024-09-09 SE3 | 2024-12-12 SE4 |
|---|---|---|---|---|---|
| PFBA | 5 ppt | < 5 | < 5 | 5.1 | < 5 |
| PFBS | 3 ppt | 4.7 | 4.4 | 4.3 | 3.6 |
| PFHxA | 3 ppt | 3.1 | 3.6 | 3.7 | 3.1 |
| PFOA | 4 ppt | 5 | 5.8 | 5.2 | 4 |
| PFPeA | 3 ppt | 3.4 | 4.2 | 4.6 | 3.6 |
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 | < 6 | < 6 |
| PFDA | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| PFHxS | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 | < 4 | < 4 |
| PFOS | 4 ppt | < 4 | < 4 | < 4 | < 4 |
| PFPeS | 4 ppt | < 4 | < 4 | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 | < 2 | < 2 |
| lithium | 9 µg/L | < 9 | < 9 | < 9 | < 9 |
Wellhouse #8 Treatment facility 00102 · sample point 102 · groundwater
| Compound | MRL | 2024-03-05 SE1 | 2024-09-09 SE2 |
|---|---|---|---|
| PFBS | 3 ppt | 8.9 | 8.1 |
| PFHxA | 3 ppt | 3.8 | 3.8 |
| PFHxS | 3 ppt | 5.4 | 4.4 |
| PFOA | 4 ppt | 4.6 | 4.2 |
| PFOS | 4 ppt | 12.7 | 10.5 |
| PFPeA | 3 ppt | 4.5 | 4.6 |
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | < 9 | < 9 |
Wellhouse #9A Treatment facility 00103 · sample point 103 · groundwater
| Compound | MRL | 2024-03-05 SE1 | 2024-09-05 SE2 |
|---|---|---|---|
| PFBS | 3 ppt | 4.9 | 5.1 |
| PFHxA | 3 ppt | 3.6 | 3.8 |
| PFOA | 4 ppt | 4.6 | 4.3 |
| PFOS | 4 ppt | 7.9 | 8.1 |
| PFPeA | 3 ppt | 3.7 | 4.1 |
| 11Cl-PF3OUdS | 5 ppt | < 5 | < 5 |
| 4:2 FTS | 3 ppt | < 3 | < 3 |
| 6:2 FTS | 5 ppt | < 5 | < 5 |
| 8:2 FTS | 5 ppt | < 5 | < 5 |
| 9Cl-PF3ONS | 2 ppt | < 2 | < 2 |
| ADONA | 3 ppt | < 3 | < 3 |
| HFPO-DA | 5 ppt | < 5 | < 5 |
| NEtFOSAA | 5 ppt | < 5 | < 5 |
| NFDHA | 20 ppt | < 20 | < 20 |
| NMeFOSAA | 6 ppt | < 6 | < 6 |
| PFBA | 5 ppt | < 5 | < 5 |
| PFDA | 3 ppt | < 3 | < 3 |
| PFDoA | 3 ppt | < 3 | < 3 |
| PFEESA | 3 ppt | < 3 | < 3 |
| PFHpA | 3 ppt | < 3 | < 3 |
| PFHpS | 3 ppt | < 3 | < 3 |
| PFHxS | 3 ppt | < 3 | < 3 |
| PFMBA | 3 ppt | < 3 | < 3 |
| PFMPA | 4 ppt | < 4 | < 4 |
| PFNA | 4 ppt | < 4 | < 4 |
| PFPeS | 4 ppt | < 4 | < 4 |
| PFTA | 8 ppt | < 8 | < 8 |
| PFTrDA | 7 ppt | < 7 | < 7 |
| PFUnA | 2 ppt | < 2 | < 2 |
| lithium | 9 µg/L | < 9 | < 9 |
Statistics by compound
| Compound | Results | Detected | Highest (date) | Mean bounds | KM median | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|---|
| PFBS | 26 | 62% | 29.8 2024-09-12 | 4.37–5.52 | 3.6 | 5.1 | 8.9 | 14.7 |
| lithium | 26 | 54% | 42.5 2024-03-07 | 12.73–16.89 | 9.6 | 18.2 | 42 | 42.5 |
| PFHxA | 26 | 46% | 6 2024-09-12 | 1.78–3.4 | <MRL | 3.7 | 3.8 | 4.5 |
| PFOA | 26 | 46% | 5.8 2024-06-03 | 2.21–4.36 | <MRL | 4.6 | 5.2 | 5.2 |
| PFPeA | 26 | 46% | 4.6 2024-09-09 | 1.87–3.48 | <MRL | 4.1 | 4.5 | 4.6 |
| PFOS | 26 | 35% | 12.7 2024-03-05 | 2.69–5.3 | <MRL | 6.4 | 8.1 | 10.5 |
| PFHxS | 26 | 19% | 5.4 2024-03-05 | 0.82–3.25 | <MRL | <MRL | 4 | 4.4 |
| PFBA | 26 | 4% | 5.1 2024-09-09 | 0.2–5 | <MRL | <MRL | <MRL | <MRL |
Never detected (22): 11Cl-PF3OUdS, 4:2 FTS, 6:2 FTS, 8:2 FTS, 9Cl-PF3ONS, ADONA, HFPO-DA, NEtFOSAA, NFDHA, NMeFOSAA, PFDA, PFDoA, PFEESA, PFHpA, PFHpS, PFMBA, PFMPA, PFNA, PFPeS, PFTA, PFTrDA, PFUnA.
Left-censored Kaplan–Meier statistics (Helsel 2005; Helsel & Lee 2006, NADA for R). Units: ppt; lithium µg/L. Each compound has one reporting limit, so the Kaplan–Meier mean equals the upper mean bound (non-detects at the MRL); the lower bound sets non-detects to 0. “<MRL” = the percentile falls below the reporting limit and cannot be estimated. These describe this system's UCMR 5 samples, not population estimates.
Sources
- EPA UCMR 5 occurrence data text files (UCMR5_All.txt; samples 2023-01-10 to 2026-04-09; data summary dated Jul 2026)
- EPA SDWIS via ECHO SDWA downloads, quarter 2026Q3
- EPA Public Water System Service Areas v3 (Mar 2026)
- US Census Bureau cartographic boundary counties 1:500k, 2024
- EPA/USGS NHDPlus V2 (medium resolution) flowlines, Strahler order 2+
Data build 52bd2907cbc3 · 2026-10-18T04:10Z · UCMR 5 release Jul2026 · SDWIS 2026Q3. Data and methods.